01
Younger patients, denser tissue
When half the breast cancers are in women under 50, the images are denser and early findings are subtler. Models trained on screening populations in their sixties have not seen enough of this.
What we do. The model is evolved against confirmed early cases from the network itself, with a hard floor on recall for dense tissue that the search cannot trade away.
02
Twenty scanners, twenty looks
A network mixes vendors, protocols, and generations of equipment. A model fit to the hub's own scanner degrades on the regional one that matters most.
What we do. Every candidate model is scored per site and per scanner, and judged by its worst site, not its average.
03
Training data skewed to late disease
Where cancer presents late, the archive is full of large, obvious findings. A model trained on it learns to wait for them.
What we do. Early cases are weighted and augmented in the evolution loop so the population of models learns to commit before the finding is large.
04
One finding per product
Buying a separate tool for breast, lung, liver, and colon means four vendors, four integrations, and still no coverage on CT, MRI, or ultrasound.
What we do. One platform reads the three modalities for the cancers that matter in your population, with one integration and one audit trail.